Statins Increase Breast Cancer Risk by over 200%

Email Print
FacebookTwitterShare

Why do one in seven women in the U.S. have breast cancer?  Unfortunately, the Powers-That-Be are too busy prescribing chemotherapy, surgery and radiation instead of searching for the underlying reasons why so many U.S. women are suffering and dying with breast cancer.  Unless we stop the flow of money to the Powers-That-Be, which includes the American Cancer Society and the Koman Foundation, there will never be progress made in this terrible illness.

Why do one in seven women have breast cancer?  One reason is the use of synthetic hormones fed to animals and other synthetic hormones prescribed to women such as medroxyprogesterone including Provera. Another reason is statin medications.

A recent study found that current users of statins for ten years or longer had  an 83% increased risk of invasive ductal carcinoma and a 97% increased risk of invasive lobular carcinoma, when compared to never-users of statins.  Among women diagnosed with hypercholesterolemia, current users of statins for ten years or longer had a 204% increased risk of invasive ductal carcinoma and a 243% increased risk of invasive lobular carcinoma.(1)

In fact, the increased risk of cancer with statin use has been reported in other studies.  All the cholesterol medications, older and newer ones, have been associated with an increased rate of cancer.(2)   In rodents, statins have been shown to cause cancer in multiple studies. (2)  Multiple studies have shown a link between low cholesterol levels and the development of cancer. (3)

Some of you may be shocked by the above numbers.  I am not.  The connection between statins and cancer is hard to pin down since most studies do not last for long periods of time and, to be properly diagnosed, cancer takes a long time to grow.  When you look at the mechanism of action of statins, and the resultant depletion of cholesterol and CoQ10, I believe long-term statin use will inevitably lead to increased risk of cancer.

Read the rest of the article

Email Print
FacebookTwitterShare